Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines
- PMID: 10203148
- DOI: 10.1203/00006450-199904010-00015
Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines
Abstract
Accumulated clinical evidence suggests that alveolar rhabdomyosarcoma (ARMS) is more aggressive than embryonal rhabdomyosarcoma (ERMS). Here, we study six childhood rhabdomyosarcoma cell lines, three ERMS and three ARMS. We have assayed the ability of the tumor cells to grow in culture and in nude mice as well as their propensity for pulmonary metastasis formation by tail vein injection. We also compared levels of c- and N-myc oncogene expression and DNA copy number. We find no correlation of histologic tumor type (i.e. ERMS versus ARMS) with growth rate in culture, but we do find suggestive correlations of histologic type with tumorigenicity (mean tumor diameter in millimeters at 6 wk: ARMS 30, ERMS 10; p1 = 0.1) and metastasis formation (ARMS 12, ERMS 0; p1 = 0.1). These properties also correlate with uniform greater overexpression of c-myc in ARMS (mean 39.3-fold, range 16-83) compared with ERMS (mean 5.3, range 4-8) (p1 = 0.05, control fibroblasts = 1). Although c-myc was often amplified in vitro (four of six lines), there was no correlation with histologic type (2/3 ARMS, 2/3 ERMS). These data on rhabdomyosarcoma cell lines derived from verified ERMS and ARMS tumors support the impression from previous clinicopathologic observations that ARMS is a more malignant form of rhabdomyosarcoma than ERMS.
Similar articles
-
N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.Mod Pathol. 1998 Dec;11(12):1222-7. Mod Pathol. 1998. PMID: 9872655
-
ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.Pediatr Dev Pathol. 2009 Jul-Aug;12(4):275-83. doi: 10.2350/08-03-0434.1. Pediatr Dev Pathol. 2009. PMID: 18788887
-
Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).Med Pediatr Oncol. 2002 Jun;38(6):398-404. doi: 10.1002/mpo.10060. Med Pediatr Oncol. 2002. PMID: 11984800
-
Classification of rhabdomyosarcoma and its molecular basis.Adv Anat Pathol. 2013 Nov;20(6):387-97. doi: 10.1097/PAP.0b013e3182a92d0d. Adv Anat Pathol. 2013. PMID: 24113309 Free PMC article. Review.
-
Rhabdomyosarcoma in children - current pathologic and molecular classification.Pol J Pathol. 2018;69(1):20-32. doi: 10.5114/pjp.2018.75333. Pol J Pathol. 2018. PMID: 29895123 Review.
Cited by
-
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.BMC Cancer. 2016 Nov 14;16(1):886. doi: 10.1186/s12885-016-2936-3. BMC Cancer. 2016. PMID: 27842508 Free PMC article.
-
Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma.Mol Cancer. 2006 Nov 2;5:53. doi: 10.1186/1476-4598-5-53. Mol Cancer. 2006. PMID: 17081294 Free PMC article.
-
Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.Cancer Genomics Proteomics. 2021 Nov-Dec;18(6):723-734. doi: 10.21873/cgp.20293. Cancer Genomics Proteomics. 2021. PMID: 34697065 Free PMC article.
-
Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.Transl Oncol. 2020 Nov;13(11):100846. doi: 10.1016/j.tranon.2020.100846. Epub 2020 Aug 14. Transl Oncol. 2020. PMID: 32805674 Free PMC article.
-
NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.Oncotarget. 2017 May 16;8(20):33086-33099. doi: 10.18632/oncotarget.16526. Oncotarget. 2017. PMID: 28380437 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources